Lanadelumab

Alternative Names: Takhzyro

Lanadelumab is a monoclonal antibody used to prevent hereditary angioedema attacks. It works by blocking plasma kallikrein, an enzyme that produces bradykinin, the substance responsible for the swelling seen in HAE. By reducing bradykinin levels, lanadelumab helps lower the frequency and severity of attacks. It is given as a subcutaneous (under the skin) injection, usually every two to four weeks. Lanadelumab is used for long-term prevention, not for treating acute attacks once they occur.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: Injection

Lanadelumab

Review Summary

0

0 Reviews

Preferred by 0 Reviewers

Based on the provided information, there are no user reviews available for the treatment 'Lanadelumab' against the disease 'Hereditary Angioedema'. The effectiveness of this treatment cannot be determined due to the lack of user ratings and reviews. More data and user feedback are needed to assess the efficacy of Lanadelumab in treating Hereditary Angioedema.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
0
1 = Very Expensive 5 = Very Affordable

0

Very Expensive
Relief Speed
0
1 = No Relief 5 = Immediate Relief

0

No Relief
Side Effects
0
1 = Intolerable Effect 5 = No Effect

0

Intolerable Effect
Treatment Line
0
1 = Third-line or more 5 = First-line

0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

0

0 Reviews
5
0%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the provided information, there are no user reviews available for the treatment 'Lanadelumab' against the disease 'Hereditary Angioedema'. The effectiveness of this treatment cannot be determined due to the lack of user ratings and reviews. More data and user feedback are needed to assess the efficacy of Lanadelumab in treating Hereditary Angioedema.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried

No reviews yet.

Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All